Clal Insurance’s Keros Therapeutics KROS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-299,000	Closed	-$12M	–	138
2023 Q2	$12M	Hold	299,000	–	–	0.14%	80
2023 Q1	$12.8M	Hold	299,000	–	–	0.19%	71
2022 Q4	$14.4M	Hold	299,000	–	–	0.22%	79
2022 Q3	$11.2M	Hold	299,000	–	–	0.15%	86
2022 Q2	$8.26M	Sell	299,000 -21,000	-7%	-$580K	0.11%	97
2022 Q1	$17.4M	Hold	320,000	–	–	0.18%	86
2021 Q4	$18.7M	Buy	320,000 +8,865	+3%	+$519K	0.2%	88
2021 Q3	$12.3M	Sell	311,135 -8,865	-3%	-$351K	0.14%	108
2021 Q2	$13.6M	Hold	320,000	–	–	0.16%	102
2021 Q1	$19.7M	Hold	320,000	–	–	0.23%	96
2020 Q4	$21.1M	Buy	+320,000	New	+$21.1M	0.29%	84